TBA
CELG

Tower Bridge Advisors’s Celgene Corp CELG Stock Holding History

Tower Bridge Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,060
Closed -$226K – 219
2019
Q3 		$226K Sell
2,060
-200
-9% -$19K 0.02% 193
2019
Q2 		$209K Sell
2,260
-200
-8% -$19K 0.02% 199
2019
Q1 		$232K Sell
2,460
-804
-25% -$70.3K 0.03% 185
2018
Q4 		$209K Sell
3,264
-1,958
-37% -$145K 0.03% 183
2018
Q3 		$467K Sell
5,222
-480
-8% -$42.4K 0.05% 150
2018
Q2 		$453K Sell
5,702
-300
-5% -$24.9K 0.05% 150
2018
Q1 		$535K Buy
6,002
+1,200
+25% +$115K 0.06% 142
2017
Q4 		$501K Buy
4,802
+2,100
+78% +$237K 0.05% 147
2017
Q3 		$394K Sell
2,702
-100
-4% -$13.6K 0.04% 157
2017
Q2 		$364K Sell
2,802
-58
-2% -$7.11K 0.04% 163
2017
Q1 		$356K Buy
2,860
+400
+16% +$47.9K 0.04% 162
2016
Q4 		$285K Sell
2,460
-226
-8% -$25.2K 0.03% 174
2016
Q3 		$281K Hold
2,686
– – 0.03% 176
2016
Q2 		$265K Hold
2,686
– – 0.03% 182
2016
Q1 		$269K Hold
2,686
– – 0.03% 183
2015
Q4 		$322K Sell
2,686
-100
-4% -$11.6K 0.04% 167
2015
Q3 		$301K Sell
2,786
-208
-7% -$25.8K 0.04% 167
2015
Q2 		$347K Buy
2,994
+290
+11% +$33.2K 0.04% 158
2015
Q1 		$312K Buy
2,704
+204
+8% +$24.4K 0.04% 167
2014
Q4 		$280K Sell
2,500
-204
-8% -$21.5K 0.03% 174
2014
Q3 		$256K Hold
2,704
– – 0.03% 178
2014
Q2 		$232K Buy
+2,704
New +$206K 0.03% 183

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Tower Bridge Advisors's CELG Position: Q4 2019 in Review

Tower Bridge Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,060 shares — an estimated $226K sold.

Tower Bridge Advisors first reported a position in CELG in Q2 2014 and held it in 22 quarters. The position peaked at $535K in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Tower Bridge Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Tower Bridge Advisors sold 2,060 Celgene Corp shares in Q4 2019, an estimated $226K.
  • Tower Bridge Advisors first reported a position in Celgene Corp in Q2 2014 and held it in 22 quarters.
  • Tower Bridge Advisors's Celgene Corp position peaked at $535K in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Tower Bridge Advisors's 13F filing for Q4 2019, filed 5 Feb 2020.